| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |